Kiranbir Josan, MD
Cardiovascular Disease (Cardiology) · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations
Hospitals listed: Cedars-Sinai Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Josan’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A140714 · Current
Licensed to practise in California · since 2016 · expires 2027-03-31 · The University of Western Ontario Schulich School of Medicine and Dentistry.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Cedars-Sinai Medical CenterLos Angeles, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Postoperative sepsis rate: 7.77 (6.11 to 9.44) · 6,132 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.2 to 14.7) · 1,174 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 134.15 (109.33 to 158.98) · 557 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.386, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.661, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.628, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.503, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.8 (3 to 4.8) · 1,174 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.8) · 2,580 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Cedars-Sinai Medical Center
Behind the star rating — Deaths: 7 better, 1 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 7.77 (6.11 to 9.44) · 6,132 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.2 to 14.7) · 1,174 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.15 (109.33 to 158.98) · 557 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.386 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.661 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.628 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.503 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.8 (3 to 4.8) · 1,174 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.8) · 2,580 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.66 (0.06 to 1.25) · 8,257 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.92 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 5.9 · 191 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.3 · 409 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 5.5 · 1,544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.5 · 1,742 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 549 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 9,504 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.28) · 29,170 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.05 to 0.32) · 31,661 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.1 (3.06 to 5.14) · 11,199 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0.47 to 2.29) · 6,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (1.24 to 2.86) · 10,075 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.2 (5.76 to 10.65) · 6,012 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.91 (0.72 to 3.11) · 2,803 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.75 (0.47 to 1.03) · 27,865 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 472 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.437 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.168 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 492 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 1,750 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.9 · 498 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.8 · 1,908 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.7 · 1,850 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 1,572 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.7 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 172 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 240 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.1 to 17.5) · 1,197 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,081 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$89,877
Medicare paid this office $89,877 for 1,136 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 903 | $53,273 | $53 |
| Long return visit (40+ min) | 57 | $8,990 | $118 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 34 | $7,991 | $178 |
| New patient visit (60+ min) | 31 | $4,324 | $139 |
| New patient visit (45+ min) | 34 | $3,796 | $112 |
See all 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 903 | $53,273 | $53 |
| Long return visit (40+ min) | 57 | $8,990 | $118 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 34 | $7,991 | $178 |
| New patient visit (60+ min) | 31 | $4,324 | $139 |
| New patient visit (45+ min) | 34 | $3,796 | $112 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $2,985 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,631 | $67 |
| Ultrasound of heart, follow-up | 43 | $908 | $21 |
| Return visit (30+ min) | 11 | $832 | $76 |
| Ultrasound of heart blood flow, valves and chambers | 52 | $717 | $14 |
| Injection of x-ray contrast during ultrasound of heart | 17 | $493 | $29 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 81 | $198 | $2 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 28 | $163 | $6 |
Who their Medicare patients are
1,136 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 17% · Women 51% · Also on Medicaid 29% · Health risk score 2.19. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 66% · Heart failure 54% · Diabetes 43% · Atrial fibrillation 39% · Chronic kidney disease 34% · Cancer 25% · Depression 24% · COPD 21% · Stroke 17% · Dementia 10%.
The office billed $402,247, Medicare allowed $120,243 and paid $89,877; for 1,543 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,136 | 1,543 | 75 | 2.19 | $402,247 | $89,877 |
| 2023 | 1,129 | 1,464 | 75 | 2.23 | $362,021 | $82,102 |
| 2022 | 929 | 1,202 | 75 | 1.90 | $312,169 | $72,045 |
| 2021 | 368 | 538 | 75 | 2.12 | $218,469 | $37,669 |
| 2020 | 180 | 379 | 74 | 2.05 | $147,872 | $30,129 |
| 2019 | 201 | 400 | 76 | 1.87 | $142,872 | $36,282 |
| 2018 | 367 | 576 | 75 | 2.06 | $100,024 | $35,156 |
| 2017 | 260 | 393 | 72 | 2.27 | $86,971 | $20,353 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 937 | $55,166 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $7,567 | $176 |
| Long return visit (40+ min) | 30 | $4,270 | $115 |
| New patient visit (60+ min) | 24 | $3,414 | $142 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 37 | $2,353 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,307 | $68 |
| Ultrasound of heart, follow-up | 38 | $850 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 44 | $638 | $14 |
| Injection of x-ray contrast during ultrasound of heart | 16 | $442 | $28 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 34 | $212 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 74 | $192 | $3 |
2022: 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 807 | $50,156 | $56 |
| New patient visit (60+ min) | 49 | $6,715 | $137 |
| Long return visit (40+ min) | 26 | $4,766 | $122 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 42 | $2,600 | $62 |
| Injection of x-ray contrast during ultrasound of heart | 23 | $657 | $29 |
| Ultrasound of heart blood flow, valves and chambers | 42 | $571 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 45 | $104 | $2 |
2021: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $9,957 | $60 |
| Long return visit (40+ min) | 32 | $4,549 | $138 |
| Long return visit (40+ min) | 29 | $3,896 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,519 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,488 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,660 | $119 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,401 | $100 |
| Return visit (30+ min) | 13 | $1,084 | $83 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 23 | $611 | $24 |
| Telehealth originating site facility fee | 28 | $584 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $233 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 22 | $193 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $164 | $13 |
2020: 10 services
| Return visit (30+ min) | 46 | $4,423 | $83 |
| Hospital discharge day management, more than 30 minutes | 31 | $3,166 | $102 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $3,016 | $131 |
| Long return visit (40+ min) | 20 | $2,408 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,138 | $69 |
| New patient visit (45+ min) | 16 | $2,105 | $132 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 39 | $1,069 | $25 |
| Short return visit (20+ min) | 18 | $975 | $51 |
| Telehealth originating site facility fee | 35 | $842 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $107 | $8 |
2019: 10 services
| Long return visit (40+ min) | 62 | $6,561 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $4,814 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $4,447 | $117 |
| Hospital discharge day management, more than 30 minutes | 37 | $3,713 | $98 |
| Initial hospital observation care per day, typically 50 minutes | 23 | $2,671 | $116 |
| Long return visit (40+ min) | 19 | $2,587 | $99 |
| New patient visit (45+ min) | 22 | $2,514 | $114 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,611 | $90 |
| Hospital observation care on day of discharge | 23 | $1,507 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,208 | $93 |
2018: 9 services
| Long return visit (40+ min) | 54 | $6,860 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,911 | $122 |
| New patient visit (45+ min) | 39 | $3,808 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,203 | $65 |
| Long return visit (40+ min) | 27 | $3,186 | $94 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,765 | $99 |
| New patient visit (60+ min) | 13 | $1,803 | $139 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 191 | $1,605 | $7 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 25 | $613 | $25 |
2017: 7 services
| New patient visit (60+ min) | 30 | $4,489 | $150 |
| Long return visit (40+ min) | 27 | $3,271 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,319 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,267 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 164 | $1,435 | $8 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,178 | $98 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 31 | $857 | $24 |
Medicaid work
$3,758 in 2024
Medicaid paid $3,758 for 180 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 180 | $3,758 |
| 2024 | 180 | 1 | 34 | $3,758 |
| 2023 | 144 | 1 | 28 | $3,795 |
| 2022 | 38 | 1 | 13 | $728 |
| 2021 | 19 | 1 | 19 | $196 |
| 2020 | 39 | 3 | 14 | $1,275 |
| 2019 | 26 | 1 | 14 | $1,889 |
| 2018 | 121 | 1 | 92 | $1,557 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 144 | $3,795 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 38 | $728 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 19 | $196 |
2020
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $791 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $344 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 15 | $140 |
2019
| Long return visit (40+ min) | 26 | $1,889 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 121 | $1,557 |
Drugs they prescribed that Part D paid
$65,560
Pharmacies billed $65,560 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 391) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
343 generic and 48 brand-name prescriptions · $65,560 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 18 | $18,401 | $1,022 |
| Rosuvastatin | 80 | $1,241 | $16 |
| Clonidine | 12 | $945 | $79 |
| Metoprolol | 46 | $607 | $13 |
| Amlodipine Besylate | 19 | $446 | $23 |
See all 10 drugs
| Eliquis | 18 | $18,401 | $1,022 |
| Rosuvastatin | 80 | $1,241 | $16 |
| Clonidine | 12 | $945 | $79 |
| Metoprolol | 46 | $607 | $13 |
| Amlodipine Besylate | 19 | $446 | $23 |
| Atorvastatin | 20 | $224 | $11 |
| Carvedilol | 25 | $153 | $6 |
| Furosemide | 20 | $78 | $4 |
| Losartan | 14 | $73 | $5 |
| Isosorbide Mononitrate Er | 12 | $65 | $5 |
Year by year
| 2024 | 391 | 85 | 0% (0) | 12% | $65,560 |
| 2023 | 194 | 50 | 0% (0) | 9% | $22,512 |
| 2022 | 251 | 78 | 0% (0) | 15% | $45,093 |
| 2021 | 631 | 103 | 0% (0) | 28% | $142,035 |
| 2020 | 632 | 107 | 0% (0) | 21% | $86,697 |
| 2019 | 594 | 101 | 0% (0) | 23% | $79,478 |
| 2018 | 450 | 97 | 0% (0) | None | $36,050 |
| 2017 | 126 | 40 | 0% (0) | 21% | $10,084 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Rosuvastatin | 33 | $793 | $24 |
| Metoprolol | 19 | $631 | $33 |
| Losartan | 17 | $345 | $20 |
| Atorvastatin | 12 | $299 | $25 |
| Amlodipine Besylate | 14 | $293 | $21 |
| Valsartan | 11 | $106 | $10 |
2022: 10 drugs
| Eliquis | 12 | $13,302 | $1,108 |
| Olmesartan-Amlodipine-Hctz | 13 | $3,095 | $238 |
| Rosuvastatin | 14 | $1,463 | $105 |
| Metoprolol | 23 | $860 | $37 |
| Losartan | 15 | $217 | $14 |
| Atorvastatin | 14 | $211 | $15 |
| Amlodipine Besylate | 20 | $163 | $8 |
| Lisinopril | 14 | $113 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $102 | $9 |
| Furosemide | 11 | $35 | $3 |
2021: 15 drugs
| Eliquis | 74 | $70,198 | $949 |
| Xarelto | 24 | $24,559 | $1,023 |
| Entresto | 16 | $15,585 | $974 |
| Brilinta | 18 | $7,675 | $426 |
| Rosuvastatin | 36 | $1,850 | $51 |
| Atorvastatin | 98 | $1,615 | $16 |
| Metoprolol | 40 | $1,014 | $25 |
| Losartan | 24 | $342 | $14 |
| Carvedilol | 28 | $323 | $12 |
| Clopidogrel | 17 | $280 | $16 |
| Amlodipine Besylate | 31 | $234 | $8 |
| Lisinopril | 22 | $205 | $9 |
| Metoprolol | 22 | $149 | $7 |
| Furosemide | 30 | $135 | $5 |
| Hydrochlorothiazide | 11 | $33 | $3 |
2020: 13 drugs
| Eliquis | 64 | $43,573 | $681 |
| Xarelto | 20 | $14,651 | $733 |
| Atorvastatin | 96 | $1,587 | $17 |
| Metoprolol | 32 | $1,236 | $39 |
| Rosuvastatin | 25 | $1,098 | $44 |
| Clopidogrel | 41 | $619 | $15 |
| Losartan | 28 | $385 | $14 |
| Amlodipine Besylate | 37 | $366 | $10 |
| Carvedilol | 23 | $287 | $12 |
| Hydralazine | 14 | $276 | $20 |
| Lisinopril | 26 | $181 | $7 |
| Digoxin | 12 | $135 | $11 |
| Furosemide | 36 | $129 | $4 |
2019: 14 drugs
| Eliquis | 62 | $36,656 | $591 |
| Xarelto | 21 | $13,336 | $635 |
| Metoprolol | 45 | $1,884 | $42 |
| Rosuvastatin | 27 | $1,560 | $58 |
| Atorvastatin | 62 | $1,021 | $16 |
| Clopidogrel | 30 | $456 | $15 |
| Amlodipine Besylate | 46 | $363 | $8 |
| Hydralazine | 18 | $327 | $18 |
| Carvedilol | 23 | $291 | $13 |
| Metoprolol | 23 | $205 | $9 |
| Furosemide | 34 | $167 | $5 |
| Lisinopril | 16 | $147 | $9 |
| Digoxin | 14 | $117 | $8 |
| Spironolactone | 12 | $62 | $5 |
2018: 10 drugs
| Eliquis | 25 | $21,949 | $878 |
| Metoprolol | 49 | $1,804 | $37 |
| Atorvastatin | 75 | $1,141 | $15 |
| Rosuvastatin | 21 | $1,132 | $54 |
| Amlodipine Besylate | 44 | $356 | $8 |
| Carvedilol | 27 | $241 | $9 |
| Furosemide | 43 | $221 | $5 |
| Lisinopril | 30 | $171 | $6 |
| Clopidogrel | 13 | $152 | $12 |
| Metoprolol | 11 | $64 | $6 |
2017: 1 drug
| Atorvastatin | 12 | $301 | $25 |
Money from drug and device companies
$130 in 2025
| 2025 | 2 | 2 | None | $130 |
| 2024 | 1 | 1 | None | $119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Corcept Therapeutics | Korlym | $77 | 1 payment
|
| Novo Nordisk | Wegovy | $52 | 1 payment
|
See all 2 published payments
| Corcept Therapeutics | Meals · 2025-12-05 | Korlym | $77 |
| Novo Nordisk | Meals · 2025-12-04 | Wegovy | $52 |
See earlier years (2024)
2024: $119
| Kiniksa Pharmaceuticals International plc | Arcalyst | $119 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 87.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1811432867
- Licence
- CA A140714California A140714: Current · expires 2027-03-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 4140 W 190th St, Torrance, CA, 90504
- NPI first listed
- 2016-12-29
- NPI last updated
- 2022-05-23
- NPI record certified
- 2022-05-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305